Title: Borneo Journal of Pharmacy
ISSN: 2621-4814 (Online)
Latest Accreditation: SINTA 2 until February 2025 by the Minister of Research and Technology/National Research and Innovation Agency, Indonesia No: 148/M/KPT/2020. The reaccreditation process is currently underway.
Subject: Pharmacy and Pharmaceutical Sciences
Frequency: Quarterly (4 issues per year in February, May, August, and November) onward February 2020
Indexed at: Scopus, EMBASESINTA 2, Dimensions, DOAJ, SHERPA RoMEO, Crossref, ResearchBib, Google Scholar, GARUDA, and more
DOI: 10.33084/bjop
Archive preservation: Indonesia OneSearch, GARUDA, and Internet Archive Scholar
Publisher: Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya in collaboration with the Central Board of the Indonesian Pharmacists Association (Pengurus Pusat Ikatan Apoteker Indonesia) 
Editor in Chief: Mohammad Rizki Fadhil Pratama

Borneo Journal of Pharmacy (Borneo J Pharm, ISSN: 2621-4814 (online)) is an international scientific platinum open-access journal managed by the Department of Pharmacy Faculty of Health Science Universitas Muhammadiyah Palangkaraya in collaboration with the Central Board of the Indonesian Pharmacists Association (Pengurus Pusat Ikatan Apoteker Indonesia) and published four times a year (in February, May, August, and November) onward February 2020 by Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya. Borneo Journal of Pharmacy accepts scientific articles as original research articles, short communication, reviews, and mini-reviews from anyone without any discrimination, as long as they submit articles that meet scientific principles.

As a distinctive feature, the Borneo Journal of Pharmacy prioritizes research articles conducted on the island of Borneo (consisting of Indonesia, Malaysia, and Brunei Darussalam) and those conducted by researchers from institutions on the island of Borneo. In every volume, there are always articles written by authors from the island of Borneo. However, articles from researchers outside the island of Borneo are also welcome.

Borneo Journal of Pharmacy publishes various scientific articles covering Pharmacy and Pharmaceutical Sciences in the fields but not limited to Pharmacology-Toxicology, Pharmacognosy-Phytochemistry, Pharmaceutical, Analytical Pharmacy-Medicinal Chemistry, Microbiology Pharmacy, Natural Product Development, Clinical-Community Pharmacy, Management Pharmacy, Pharmaceutical Education, and Pharmaceutical Regulations.

                                             

20 May 2025

ANNOUNCEMENT: Important Changes to Borneo Journal of Pharmacy's Aims & Scope – Focused on Borneo's Research Excellence

Dear Esteemed Authors, Reviewers, and Readers,

We are delighted to share the exciting news that the Borneo Journal of Pharmacy (Borneo J Pharm) has recently achieved a significant milestone by being officially indexed in Scopus! This prestigious recognition is a testament to the quality and relevance of the research we publish, and we are profoundly grateful for the contributions of our dedicated authors, diligent reviewers, and supportive readers.

In light of this achievement and our commitment to further elevate research from and about Borneo Island, we are announcing an important refinement to the Aims & Scope of the Borneo Journal of Pharmacy, effective June 1st, 2025, or starting from Volume 8 Issue 3 2025.

Moving forward, the Borneo Journal of Pharmacy will exclusively focus on publishing research from authors affiliated with institutions on the Borneo Islands (Indonesia, Malaysia, and Brunei Darussalam), and/or research predominantly conducted within the Borneo Island region.

This strategic shift aims to:

  • Strengthen the visibility and impact of research originating from Borneo.
  • Foster collaboration and knowledge exchange among researchers within the Borneo region.
  • Position Borneo Journal of Pharmacy as the leading platform for pharmaceutical research directly relevant to the unique context and challenges of Borneo.

Consequently, we regret to inform that, with the exception of collaborations as detailed below, we will no longer be able to accommodate new manuscript submissions from authors whose institutions are outside of Indonesia (in general) and, more specifically, outside of the Borneo Island region.

Exception for International Collaborations:

To continue promoting global scientific discourse while maintaining our core focus, we will consider manuscripts from authors outside the specified Borneo region only if the research involves a genuine and active collaboration with researchers affiliated with institutions on Borneo Island. This means the partnership should extend beyond joint authorship and involve substantive joint research efforts conducted by researchers from both parties. Evidence of such collaboration, including methodological contributions, data collection, or significant intellectual input from Borneo-based researchers, will be required.

We understand that this change may impact some of our previous contributors, and we sincerely apologize for any inconvenience this may cause. This decision has been made to better serve our mission and to maximize the regional and global impact of Borneo-focused pharmaceutical science.

We encourage all researchers from or collaborating with institutions on Borneo Island to continue submitting their high-quality work to us. We look forward to receiving your valuable contributions as we embark on this exciting new phase.

For any inquiries regarding these changes, please do not hesitate to contact our editorial office at bjop@umpr.ac.id.

Sincerely,

The Editorial Board of Borneo Journal of Pharmacy

Vol. 8 No. 4 (2025): Borneo Journal of Pharmacy

The publication of the Borneo Journal of Pharmacy positively participates in disseminating research and review of science and technology development conducted by lecturers and researchers, primarily from Universitas Muhammadiyah Palangkaraya and other universities.

Published: 2025-11-30

Pharmacology-Toxicology

  • Integrative Analysis of the Pharmacological Activities of Lumbricus rubellus: Evidence from Preclinical and Clinical Research

    Iyan Hardiana (1), Elly Wahyudin (2), Muhammad Aswad (3), Rina Agustina (4)
    (1) Sekolah Tinggi Ilmu Kesehatan Buleleng , Indonesia ,
    (2) Universitas Hasanuddin , Indonesia ,
    (3) Universitas Hasanuddin , Indonesia ,
    (4) Universitas Hasanuddin , Indonesia ,
    313-325
    Abstract Views : 43
    Download :19
    DOI: https://doi.org/10.33084/bjop.v8i4.8741
  • Pogostemon cablin from North Konawe Targets MCF-7 Cells and Inflammatory Responses Through Protein Denaturation and Membrane Stabilization

    Adryan Fristiohady (1), Jafriati Jafriati (2), Irvan Anwar (3), Rathapon Asasutjarit (4), La Ode Muhammad Julian Purnama (5), Lidya Agriningsih Haruna (6), Agung Wibawa Mahatva Yodha (7), Hariana Hariana (8), Mentarry Bafadal (9)
    (1) Universitas Halu Oleo , Indonesia ,
    (2) Universitas Halu Oleo , Indonesia ,
    (3) Universitas Halu Oleo , Indonesia ,
    (4) Thammasat University , Thailand ,
    (5) Thammasat University , Thailand ,
    (6) Thammasat University , Thailand ,
    (7) Politeknik Bina Husada Kendari , Indonesia ,
    (8) Universitas Halu Oleo , Indonesia ,
    (9) Universitas Mulawarman , Indonesia ,
    326-334
    Abstract Views : 22
    Download :29
    DOI: https://doi.org/10.33084/bjop.v8i4.10168

Pharmacognosy-Phytochemistry

  • Phenolic, Flavonoid, and Antioxidant Profiles of Sago (Metroxylon sagu Rottb.) Leaf Ethanol Extract

    Muhammad Isrul (1), Bai Athur Ridwan (2), Ahmad Syaiful (3), Azlimin Azlimin (4), Tenri Zulfa Ayu Dwi Putri (5), Eviyanti Jambilu (6), Mahfuzun Bone (7), Vina Maulidya (8)
    (1) Universitas Mandala Waluya , Indonesia ,
    (2) Universitas Mandala Waluya , Indonesia ,
    (3) Universitas Mandala Waluya , Indonesia ,
    (4) Universitas Mandala Waluya , Indonesia ,
    (5) Universitas Mandala Waluya , Indonesia ,
    (6) Universitas Mandala Waluya , Indonesia ,
    (7) Universitas Mulawarman , Indonesia ,
    (8) Universitas Mulawarman , Indonesia ,
    335-343
    Abstract Views : 35
    Download :12
    DOI: https://doi.org/10.33084/bjop.v8i4.7818

Pharmaceutical

Analytical Pharmacy-Medicinal Chemistry

  • Kelor (Moringa oleifera) Bioactive Compounds as Potential Anti-Breast Cancer Agents: In Silico Studies

    Saeful Amin (1), Vanessa Angelica Sheryl (2), Ade Yeni Aprillia (3), Anisa Pebiansyah (4)
    (1) Universitas Bakti Tunas Husada , Indonesia ,
    (2) Universitas Bakti Tunas Husada , Indonesia ,
    (3) Universitas Bakti Tunas Husada , Indonesia ,
    (4) Universitas Bakti Tunas Husada , Indonesia ,
    353-367
    Abstract Views : 26
    Download :0
    DOI: https://doi.org/10.33084/bjop.v8i4.7435

Microbiology Pharmacy

Natural Product Development

  • The Protective Effect of Amorphophallus oncophyllus against Indomethacin-Induced Duodenal Mucosal Injury in Rats via Inhibition of Inflammatory Cell Infiltration

    Yuani Setiawati (1), Rochmah Kurnijasanti (2), Annette D'Arqom (3), Jusak Nugraha (4), Oski Illiandri (5), Sri Agus Sudjarwo (6)
    (1) Airlangga University , Indonesia ,
    (2) Airlangga University , Indonesia ,
    (3) Airlangga University , Indonesia ,
    (4) Airlangga University , Indonesia ,
    (5) Lambung Mangkurat University , Indonesia ,
    (6) Airlangga University , Indonesia ,
    Abstract Views : 14
    DOI: https://doi.org/10.33084/bjop.v8i4.10233

Management Pharmacy

  • Interventions on Costs and Survival Rates of Lung Cancer Patients

    Fitriana Yuliastuti (1), Nurfina Dian Kartikawati (2), Missya Putri Kurnia Pradani (3), Cut Dewi Bunga (4), Roshan Kumar Mahato (5)
    (1) Universitas Muhammadiyah Magelang , Indonesia ,
    (2) Universitas Muhammadiyah Magelang , Indonesia ,
    (3) Universitas Muhammadiyah Magelang , Indonesia ,
    (4) Universitas Muhammadiyah Magelang , Indonesia ,
    (5) Khon Kaen University , Thailand ,
    Abstract Views : 12
    DOI: https://doi.org/10.33084/bjop.v8i4.10049

Pharmaceutical Regulations

View All Issues